For example, as mentioned in Section 3 above, mice expressing a hepatocyte-specific dominant negative RARα that suppresses the signaling of all endogenous RARs develop hepatic steatosis, with impaired capacity for mitochondrial β-oxidation of fatty acids, which can be reversed with RA treatment [56]. This evidence concerns the gene RARA and fatty liver disease.